semaj83/ctmatch_classification huggingface dataset:
Patient description: The patient is a 37-year-old woman who came to the clinic for a routine Pap smear. The test revealed stage 1B of cervical cancer. The patient tested positive for HPV 16. She has three sexual partners and four children. She underwent tubal ligation. She smokes 30 packs/year and drinks alcohol frequently. She is otherwise healthy. She was offered a radical hysterectomy.

Clinical trial eligibility criteria: eligible ages (years): 9.0-45.0,  Papillomavirus Infections Participant is a Chinese female judged to be in good physical health based on medical history and physical examination Not a woman of childbearing potential (WOCBP) or if of WOCBP, has not had sex with males or has had sex with males and used effective contraception as defined in Appendix 2 since the first day of participant's last menstrual period through Day 1. And the participant understands and agrees that during the Day 1 through Month 7 period, she should not have sexual intercourse with males without effective contraception, and that the use of the rhythm method, withdrawal, and emergency contraception are not acceptable methods Has a lifetime history of 0 to 4 male and/or female sexual partners at the time of enrollment. Male partner is defined as someone with whom the participant has penile penetrative sexual intercourse. Female partner is defined as someone who has contacted, either by penetrative (with fingers or other objects) or non-penetrative means, the participant's genitalia during sexual activity  Known allergy to any vaccine component, including aluminum, yeast, or (nuclease, Nycomed™). An allergy to vaccine components is defined as an allergic reaction that met the for serious adverse event History of severe allergic reaction (e.g. swelling of the mouth and throat, difficulty breathing, hypotension, or shock) that required medical intervention Known thrombocytopenia or any coagulation disorder that would contraindicate intramuscular injections Has a fever (defined as an axillary temperature ≥37.1°C) within 24 hours prior to the Day 1 vaccination Has any history of abnormal Pap test showing squamous intraepithelial lesion (SIL) or atypical squamous cells undetermined significance (ASC-US), atypical squamous cells cannot HSIL (ASC-H), atypical glandular cells, or biopsy showing cervical intraepithelial neoplasia (CIN), adenocarcinoma in situ or cervical cancer History of external genital wart, vulvar intraepithelial neoplasia (VIN), vaginal intraepithelial neoplasia (VaIN), vulvar cancer or vaginal cancer History of a positive test for HPV Currently immunocompromised or has been diagnosed as having congenital or acquired immunodeficiency, human immunodeficiency virus (HIV) infection, lymphoma, leukemia, systemic lupus erythematosus (SLE), rheumatoid arthritis, juvenile rheumatoid arthritis (JRA), inflammatory bowel disease, or other autoimmune condition
Patient description: The patient is a 37-year-old woman who came to the clinic for a routine Pap smear. The test revealed stage 1B of cervical cancer. The patient tested positive for HPV 16. She has three sexual partners and four children. She underwent tubal ligation. She smokes 30 packs/year and drinks alcohol frequently. She is otherwise healthy. She was offered a radical hysterectomy.

Clinical trial eligibility criteria: eligible ages (years): 18.0-65.0,  Uterine Cervical Neoplasms HIV/AIDS HIV-infected women confirmed through medical records 2. Women residing within Lusaka district and plans to stay in this area for the next 6 months 3. Women between 18 and 65 years of age (age bracket as per Zambian guidelines for cervical cancer screening) 4. Able and willing to consent 5. Willing to undergo a pelvic examination and cancer screening 6. Has had sexual intercourse before 7. Agrees to have follow-up appointment in 6 months  Women with a history of cervical cancer or previous hysterectomy (where the cervix was also removed) 2. Pregnant women or women who plan to get pregnant within the next 6 months 3. Women who have been vaccinated against HR-HPV
Patient description: The patient is a 37-year-old woman who came to the clinic for a routine Pap smear. The test revealed stage 1B of cervical cancer. The patient tested positive for HPV 16. She has three sexual partners and four children. She underwent tubal ligation. She smokes 30 packs/year and drinks alcohol frequently. She is otherwise healthy. She was offered a radical hysterectomy.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Uterine Cervical Neoplasms Primary squamous cell carcinoma, adenocarcinoma, or adenosquamous carcinoma of the uterine cervix Stage IB1 carcinoma, <4 CMS, (FIGO 2009) Preoperative pelvic MRI indicating tumor diameter < 4 cm (at least two dimensions,) and no parametrial invasion. Exceptionally it can be considered acceptable Vaginal Ultrasound, only if your Institution have internally validated this technique for cervical cancer. Otherwise it cannot be accepted Preoperative either (Abdominal) CT scan or MRI or PET-CT ruling out extracervical metastatic disease Performance status ECOG 0-1 Age 18 years or older Radical hysterectomy Type II-III or Type B-C by MIS (laparoscopic or robotic) or open surgery Patient was operated during the years 2013-2014 within the ESGO area Bilateral pelvic lymphadenectomy (+ sentinel LN biopsy)  No past medical history of any invasive tumor No previous abdominal or pelvic radiotherapy of any type (including braquitherapy) No history of preoperative neoadjuvant chemotherapy  No cervical conization previous to surgery No suspicious positive pelvic or paraaortic nodes or metastatic disease on PET CT, MRI, or CT There is none uterine diameter larger than 12cm No Conversion from MIS to laparotomy
Patient description: The patient is a 37-year-old woman who came to the clinic for a routine Pap smear. The test revealed stage 1B of cervical cancer. The patient tested positive for HPV 16. She has three sexual partners and four children. She underwent tubal ligation. She smokes 30 packs/year and drinks alcohol frequently. She is otherwise healthy. She was offered a radical hysterectomy.

Clinical trial eligibility criteria: eligible ages (years): 18.0-50.0,  Cervix Cancer Women in fertile age  severe comorbidities
Patient description: The patient is a 37-year-old woman who came to the clinic for a routine Pap smear. The test revealed stage 1B of cervical cancer. The patient tested positive for HPV 16. She has three sexual partners and four children. She underwent tubal ligation. She smokes 30 packs/year and drinks alcohol frequently. She is otherwise healthy. She was offered a radical hysterectomy.

Clinical trial eligibility criteria: eligible ages (years): 18.0-65.0,  Abdominal Hysterectomy To be 18 years and older No smoking No history of bleeding disorder No history of favism No history of uterus, ovary, cervical cancer  Need to injection of vasopressor drugs Surgeon disagreement
Patient description: The patient is a 37-year-old woman who came to the clinic for a routine Pap smear. The test revealed stage 1B of cervical cancer. The patient tested positive for HPV 16. She has three sexual partners and four children. She underwent tubal ligation. She smokes 30 packs/year and drinks alcohol frequently. She is otherwise healthy. She was offered a radical hysterectomy.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Uterine Cervical Neoplasm Uterine Neoplasms Patients undergoing hysteroscopy  Pregnancy
Patient description: The patient is a 37-year-old woman who came to the clinic for a routine Pap smear. The test revealed stage 1B of cervical cancer. The patient tested positive for HPV 16. She has three sexual partners and four children. She underwent tubal ligation. She smokes 30 packs/year and drinks alcohol frequently. She is otherwise healthy. She was offered a radical hysterectomy.

Clinical trial eligibility criteria: eligible ages (years): 18.0-45.0,  Congenital Diaphragmatic Hernia Patient is a pregnant woman between 18 and 45 years of age Singleton pregnancy The fetuses will be 28+0/7 to 31+6/7 weeks of gestational age Confirmed diagnosis of severe left or right-sided CDH of the fetus: Observed/expected total lung volume equal to or less than 0.32 with more than 21% of liver herniated into the hemithorax. (Ideally calculated between 28+0/7 and 31+6/7 weeks' gestation.) Normal fetal echocardiogram or echocardiogram with a minor anomaly (such a small VSD) that in the opinion of the pediatric cardiologist will not affect postnatal outcome Normal fetal karyotype or microarray The mother must be healthy enough to have surgery Patient and father of the baby provide signed informed consent that details the maternal and fetal risks involved with the procedure Patient willing to remain in Houston for the duration following balloon placement until delivery  Contraindication to abdominal surgery, fetoscopic surgery, or general anesthesia Allergy to latex Allergy or previous adverse reaction to a study medication specified in this protocol Preterm labor, preeclampsia, or uterine anomaly (e.g., large fibroid tumor) in the index pregnancy Fetal aneuploidy, known structural genomic variants, other major fetal anomalies that may impact the fetal/neonatal survival or known syndromic mutation Suspicion of major recognized syndrome (e.g. Fryns syndrome) on ultrasound or MRI Maternal BMI >40 High risk for fetal hemophilia
Patient description: The patient is a 37-year-old woman who came to the clinic for a routine Pap smear. The test revealed stage 1B of cervical cancer. The patient tested positive for HPV 16. She has three sexual partners and four children. She underwent tubal ligation. She smokes 30 packs/year and drinks alcohol frequently. She is otherwise healthy. She was offered a radical hysterectomy.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Cervical Cancer Breast Cancer Contraceptive Usage Sexually Transmitted Diseases -Scheduled to leave jail within 3 days  not actively intoxicated not show severe psychological distress
Patient description: The patient is a 37-year-old woman who came to the clinic for a routine Pap smear. The test revealed stage 1B of cervical cancer. The patient tested positive for HPV 16. She has three sexual partners and four children. She underwent tubal ligation. She smokes 30 packs/year and drinks alcohol frequently. She is otherwise healthy. She was offered a radical hysterectomy.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Pregnancy Related Any patient scheduled for a postpartum tubal ligation at the Women and Infants Center will be eligible for the study  age less than 18 years old allergy to either local anesthetic class (amide or ester) contraindication to spinal anesthesia
Patient description: The patient is a 37-year-old woman who came to the clinic for a routine Pap smear. The test revealed stage 1B of cervical cancer. The patient tested positive for HPV 16. She has three sexual partners and four children. She underwent tubal ligation. She smokes 30 packs/year and drinks alcohol frequently. She is otherwise healthy. She was offered a radical hysterectomy.

Clinical trial eligibility criteria: eligible ages (years): 25.0-65.0,  Cervical Cancer Pathological Screening Smear Women followed for a cervical pathology requiring endocervical curettage AGC type (glandular cell atypia) with positive HPV test Frottis ASC-H, LSIL, ASCUS HPV + with non-contributive colposcopy (ZT3)  Pregnant woman Women under the age of 25 or over 65 Stenosis of the neck complete or tight not allowing the possible insertion of a curette (inadequate size cervical orifice and material) Presence of a vaginal lesion on colposcopic examination
Patient description: The patient is a 37-year-old woman who came to the clinic for a routine Pap smear. The test revealed stage 1B of cervical cancer. The patient tested positive for HPV 16. She has three sexual partners and four children. She underwent tubal ligation. She smokes 30 packs/year and drinks alcohol frequently. She is otherwise healthy. She was offered a radical hysterectomy.

Clinical trial eligibility criteria: eligible ages (years): 25.0-49.0,  Human Papillomavirus 16 Human Papillomavirus 18 Papillomavirus Infections Cervical Cancer Pre-Cancerous Dysplasia Women with no previous history of hysterectomy aged 25-49 years old no previous history of treatment for cervical cancer provided written informed consent  Women who are under 25 or over 49 years of age who have previously had a hysterectomy or been treated for cervical cancer unable to provided informed consent
Patient description: The patient is a 37-year-old woman who came to the clinic for a routine Pap smear. The test revealed stage 1B of cervical cancer. The patient tested positive for HPV 16. She has three sexual partners and four children. She underwent tubal ligation. She smokes 30 packs/year and drinks alcohol frequently. She is otherwise healthy. She was offered a radical hysterectomy.

Clinical trial eligibility criteria: eligible ages (years): 18.0-40.0,  Cervical Cancer Part 1 for Neoadjuvant Chemotherapy Patients must have histologically confirmed invasive cervical cancer with adenocarcinoma, adenosquamous or squamous histology and FIGO 2018 IB2 measuring ≥2cm to <4cm by radiological imaging (MRI) Patients must be premenopausal and wish to preserve fertility At time of registration, patient may not have had any prior therapy to treat their cancer lesion Eastern Cooperative Group (ECOG) performance status ≤ 2 Within 7 days of the proposed start of treatment, patients must have normal organ and marrow function No evidence of active uncontrolled infection (patients on antibiotics are eligible) Patient must have disease that is measurable per the Response Evaluation in Solid Tumors (RECIST) 1.1 Ability to understand and willing to sign a written informed consent document  Part 1 for Neoadjuvant Chemotherapy Patients who have had chemotherapy or radiotherapy or surgery for their cancer Patients who are receiving any other investigational agents Patients with other cancers requiring ongoing treatment Patients with known / evidence of brain metastases are excluded from participation in this clinical trial History of allergic reactions attributed to compounds of similar chemical or biologic composition to paclitaxel, carboplatin, or cisplatin or other agents used in study Uncontrolled inter-current illness including, but not limited to, ongoing or active infection, symptomatic congestive heart failure, unstable angina pectoris, cardiac arrhythmia, or psychiatric illness/social situations that would limit compliance with study requirements Patients who are pregnant or breastfeeding Any other condition that would, in the Investigator's judgment, contraindicate the patient's participation in the clinical study due to safety concerns or compliance with clinical study procedures, e.g., infection/inflammation, intestinal obstruction, unable to swallow medication, social/ psychological issues. Part 2
Patient description: The patient is a 37-year-old woman who came to the clinic for a routine Pap smear. The test revealed stage 1B of cervical cancer. The patient tested positive for HPV 16. She has three sexual partners and four children. She underwent tubal ligation. She smokes 30 packs/year and drinks alcohol frequently. She is otherwise healthy. She was offered a radical hysterectomy.

Clinical trial eligibility criteria: eligible ages (years): 15.0-44.0,  Fetal Alcohol Spectrum Disorders Drinking pregnant women who are defined as women who Drank in the 3 months prior to pregnancy and/or Drank alcohol at least once at any time during the prenatal period Gestational age less than or equal to 16 weeks, but not more than 20 weeks at intake  Non-drinking pregnant women who are defined as women who have not had any alcohol during the past 30 days Gestational age >20 weeks
Patient description: The patient is a 37-year-old woman who came to the clinic for a routine Pap smear. The test revealed stage 1B of cervical cancer. The patient tested positive for HPV 16. She has three sexual partners and four children. She underwent tubal ligation. She smokes 30 packs/year and drinks alcohol frequently. She is otherwise healthy. She was offered a radical hysterectomy.

Clinical trial eligibility criteria: eligible ages (years): 7.0-80.0,  Neuroendocrine Tumors suspected or confirmed untreated NET patients previously performed 18F-FDG PET/CT signed written consent  pregnancy breastfeeding known allergy against TATE any medical condition that in the opinion of the investigator, may significantly interfere with study compliance
Patient description: The patient is a 37-year-old woman who came to the clinic for a routine Pap smear. The test revealed stage 1B of cervical cancer. The patient tested positive for HPV 16. She has three sexual partners and four children. She underwent tubal ligation. She smokes 30 packs/year and drinks alcohol frequently. She is otherwise healthy. She was offered a radical hysterectomy.

Clinical trial eligibility criteria: eligible ages (years): 6.0-80.0,  Children, Adult prepubertal children (6-9y) postpubertal children (15-18y) young adults (18-24y) healthy non-falling older adults (65-80y) will be included if they 1) did not experience two or more falls during normal daily activities in the preceding year and 2) have no cognitive impairment (tested with Mini-Mental state examination)  inability to speak and understand Dutch; 2. inability to maintain independent unsupported stance for 60 seconds; 3. current diagnosis of neurological or sensory disorders; 4. recurrent dizziness; 5. obesity ; 6. a history of orthopaedic disorders; 7. surgical operation of the lower extremity during last two years; 8. use of drugs affecting the CNS or known to affect balance control
Patient description: The patient is a 37-year-old woman who came to the clinic for a routine Pap smear. The test revealed stage 1B of cervical cancer. The patient tested positive for HPV 16. She has three sexual partners and four children. She underwent tubal ligation. She smokes 30 packs/year and drinks alcohol frequently. She is otherwise healthy. She was offered a radical hysterectomy.

Clinical trial eligibility criteria: eligible ages (years): 21.0-65.0,  Health Knowledge, Attitudes, Practice All Women 21-65 years with diagnosis of abnormal pap smear presenting to Women's Health Colposcopy Clinic at WCMC Access to a smartphone English or Spanish Speaking  Pregnant women Non-English or Spanish speakers
Patient description: The patient is a 37-year-old woman who came to the clinic for a routine Pap smear. The test revealed stage 1B of cervical cancer. The patient tested positive for HPV 16. She has three sexual partners and four children. She underwent tubal ligation. She smokes 30 packs/year and drinks alcohol frequently. She is otherwise healthy. She was offered a radical hysterectomy.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Cervical Cancer Cervical cancer histopathological diagnosis Clinical stage IB1 or IIA1 CC Treated with radical hysterectomy (RH) with bilateral pelvic lymphadenectomy (BPL)  Double primary tumors Treatment regimens other than standard treatment Poor quality formalin-fixed paraffin-embedded tissue blocks
Patient description: The patient is a 37-year-old woman who came to the clinic for a routine Pap smear. The test revealed stage 1B of cervical cancer. The patient tested positive for HPV 16. She has three sexual partners and four children. She underwent tubal ligation. She smokes 30 packs/year and drinks alcohol frequently. She is otherwise healthy. She was offered a radical hysterectomy.

Clinical trial eligibility criteria: eligible ages (years): 19.0-57.0,  Diet, Healthy adults aged 19-57 years male to female ratio (1:1 ratio) BMI 19-35 kg/m2 Currently living in Amman without significant apparent diseases Able to drink the tested herbal tea twice a day  Have chronic diseases such as diabetes, hypertension, cardiovascular or endocrine diseases or disabilities Using medical drugs and/or supplements Below 19 or above 57 years participation in clinical trials within the last 2 months use of lipid-lowering drugs, or diabetic medication Lactating and pregnant women will be also excluded
Patient description: The patient is a 37-year-old woman who came to the clinic for a routine Pap smear. The test revealed stage 1B of cervical cancer. The patient tested positive for HPV 16. She has three sexual partners and four children. She underwent tubal ligation. She smokes 30 packs/year and drinks alcohol frequently. She is otherwise healthy. She was offered a radical hysterectomy.

Clinical trial eligibility criteria: eligible ages (years): 21.0-65.0,  Cervical Cancer Female of at least 21 years of age and not over 65 presenting who need routine cervical cancer screening per national guidelines  prior history of cervical cancer or a positive Pap smear, have had a total hysterectomy (removal of uterus and cervix), or currently enrolled in any other cancer prevention study
Patient description: The patient is a 37-year-old woman who came to the clinic for a routine Pap smear. The test revealed stage 1B of cervical cancer. The patient tested positive for HPV 16. She has three sexual partners and four children. She underwent tubal ligation. She smokes 30 packs/year and drinks alcohol frequently. She is otherwise healthy. She was offered a radical hysterectomy.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Thyroid Neoplasms Genetic Susceptibility Radiation Exposure Diganosis of thyroid cancer during the followup or selected as a control matched on gender, date of birth and age at skin hemangioma diagnosis  No available adress Refusal